- Home
- EXEL vs AM Comparison
EXEL vs AM Comparison
Compare EXEL & AM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXEL | AM |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.2B |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EXEL | AM |
|---|---|---|
| Price | $54.66 | $23.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 4 |
| Target Price | ★ $46.50 | $22.50 |
| AVG Volume (30 Days) | ★ 2.5M | 2.0M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.11% |
| EPS Growth | ★ 57.95 | 3.61 |
| EPS | ★ 0.79 | 0.25 |
| Revenue | $452,477,000.00 | ★ $1,188,426,000.00 |
| Revenue This Year | $13.61 | $4.84 |
| Revenue Next Year | $13.13 | $7.05 |
| P/E Ratio | ★ $67.38 | $90.80 |
| Revenue Growth | N/A | ★ 7.43 |
| 52 Week Low | $33.76 | $16.77 |
| 52 Week High | $53.93 | $23.84 |
Technical Indicators
Market Signals| Indicator | EXEL | AM |
|---|---|---|
| Relative Strength Index (RSI) | 65.70 | 70.76 |
| Support Level | $40.17 | $22.45 |
| Resistance Level | N/A | $23.84 |
| Average True Range (ATR) | 1.52 | 0.48 |
| MACD | -0.04 | 0.18 |
| Stochastic Oscillator | 90.23 | 99.29 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.